Concepedia

Shefali Mody

SM

Statistics

Publications

4

Citations

384

H-Index

4

Active since

2007

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Shefali Mody is an author at Janssen (United States) specializing in health care costs, hospitalization costs, and pharmacy.

Publications per year

2007–2010

4

Publications

4

Haemoglobin level and its clinical impact in a cohort of patients with COPD

Claudia Côté, Marya D. Zilberberg, Shefali Mody et al. · European Respiratory Journal · 2007 · 259 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US

M. Raut, Jeff Schein, Shefali Mody et al. · Current Medical Research and Opinion · 2009 · 76 citations

Pharmacy, Pharmacoeconomics, Health Economics +16

Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)

Chris M Kozma, Michael Dickson, Monika Raut et al. · Journal of Medical Economics · 2010 · 35 citations · Full text

Health Professions, Health Services Administration, Pharmacoeconomics +17

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study

Christopher R. Frei, Theresa Jaso, Eric M. Mortensen et al. · Current Medical Research and Opinion · 2009 · 14 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +13

1–4 of 4